Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial

出版年份 2016 全文链接

标题

作者

关键词

出版物

Volume 101, Issue 7, Pages 821-829

出版商

Ferrata Storti Foundation (Haematologica)

发表日期

2016-04-22

DOI

10.3324/haematol.2016.143644

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discuss science. Find collaborators. Network.

Join a conversation